These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22280197)

  • 1. The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.
    Zhu TY; Tam LS; Li EK
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):53-69. PubMed ID: 22280197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of systemic lupus erythematosus in Asia: the current state.
    Mak A
    Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of lupus.
    Clarke A
    Am J Manag Care; 2001 Oct; 7(16 Suppl):S496-501. PubMed ID: 11680782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis.
    Aghdassi E; Zhang W; St-Pierre Y; Clarke AE; Morrison S; Peeva V; Landolt-Marticorena C; Su J; Reich H; Scholey J; Herzenberg A; Pope JE; Peschken C; ; Wither JE; Fortin PR
    J Rheumatol; 2011 Apr; 38(4):658-66. PubMed ID: 21159829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus with neuropsychiatric manifestation incurs high disease costs: a cost-of-illness study in Hong Kong.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Rheumatology (Oxford); 2009 May; 48(5):564-8. PubMed ID: 19269959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of systemic lupus erythematosus.
    Panopalis P; Clarke AE; Yelin E
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):695-704. PubMed ID: 23218432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
    Meacock R; Dale N; Harrison MJ
    Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of SLE: prevalence, health disparities and socioeconomic impact.
    Carter EE; Barr SG; Clarke AE
    Nat Rev Rheumatol; 2016 Oct; 12(10):605-20. PubMed ID: 27558659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
    Kariburyo F; Xie L; Sah J; Li N; Lofland JH
    J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States.
    Garris C; Oglesby A; Sulcs E; Lee M
    Lupus; 2013 Sep; 22(10):1077-86. PubMed ID: 23920376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic factors in lupus erythematosus.
    Meller S; Homey B; Ruzicka T
    Autoimmun Rev; 2005 Apr; 4(4):242-6. PubMed ID: 15893719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
    Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
    Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The socioeconomic burden of SLE.
    Lau CS; Mak A
    Nat Rev Rheumatol; 2009 Jul; 5(7):400-4. PubMed ID: 19506585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus.
    Lacaille D; Clarke AE; Bloch DA; Danoff D; Esdaile JM
    J Rheumatol; 1994 Mar; 21(3):448-53. PubMed ID: 8006887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic consequences of systemic lupus erythematosus.
    Barber MRW; Clarke AE
    Curr Opin Rheumatol; 2017 Sep; 29(5):480-485. PubMed ID: 28520683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
    Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
    J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.